Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog.
Cannabis company Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) reported a 52.4% year-over-year increase in second-quarter revenue to $72.8 million, attributing
Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, has signed a distribution agreement for Praesidio Health products with
Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY), which closed its acquisition of rival Aphria, Inc. (APHA) in 2021, could face a lawsuit brought by former Aphria shareholders.